Novel glycodendrimers self-assemble to nanoparticles which function as polyvalent ligands in vitro and in vivo.
Novartis Pharma AG, P.O. Box, 4002, Basel, Switzerland. gebhard.thoma@pharma.novartis.com
Gebhard
G
Thoma
Andreas G
AG
Katopodis
Nicolas
N
Voelcker
Rudolf O
RO
Duthaler
Markus B
MB
Streiff
D007075:Immunoglobulin M / Q000737:chemistry; D007202:Indicators and Reagents; D008024:Ligands; D009682:Magnetic Resonance Spectroscopy; D018625:Microscopy, Atomic Force; D008863:Microspheres; D009844:Oligosaccharides / Q000138:chemical synthesis / Q000737:chemistry*; D010316:Particle Size; D011485:Protein Binding; D013696:Temperature
D007075:Immunoglobulin M; D007202:Indicators and Reagents; D008024:Ligands; D009844:Oligosaccharides